Showing 1 - 20 results of 76,108 for search '(( i marked increase ) OR ((( a ((non decrease) OR (mean decrease)) ) OR ( a marker increase ))))', query time: 1.32s Refine Results
  1. 1

    Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

    Published 2021
    “…<p>Immunohistochemical analysis of six-week-old control and <i>Ubr5</i><sup><i>mt</i></sup> tibial AC examined for markers of canonical HH pathway activity. Relative to (A, C) control, (B, D) <i>Ubr5</i><sup><i>mt</i></sup> AC displayed increased staining intensities for PTCH1 (A, B) and GLI1 (C, D) with GLI1 exhibiting expanded expression domains (D, double-headed arrows). …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    The proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases in <i>APC</i>-mutant colon tissues from FAP patients. by Tao Zhang (43681)

    Published 2020
    “…Results show that, in normal crypts, the distribution and proportion of cells staining for ALDH1 and CGA are very similar. In contrast, in <i>APC</i>-mutant tissues from FAP patients, the proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases. …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

    Published 2024
    “…RBP-4 was increased in the sitagliptin non-ischemic group (SIT-N) compared to CON-N. There was a significant decrease in RBP-4 in the sitagliptin ischemic (SIT-I) myocardium compared to CON-I to levels similar to the CON-N myocardium. …”
  15. 15
  16. 16

    DCD is strikingly decreased in HS lesions. by Margaret Coates (6058580)

    Published 2019
    “…Non-lesional and lesional samples were compared using a paired t-test. …”
  17. 17
  18. 18
  19. 19
  20. 20

    Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

    Published 2021
    “…<p><b>(A)</b> Kaplan-Meier survival curve. Tamoxifen was given by gavage for 6 days to mice with the genotype <i>Mll1</i><sup><i>FC/+; Vil-Cre-ERT2/+</i></sup> (n = 12) and <i>Mll1</i><sup><i>FC/FC; RC/+</i></sup> (n = 18). …”